Skip to main navigation
  • HOME
  • ABOUT ENZON
  • ROYALTY PRODUCTS
  • INVESTORS & MEDIA

    Investor Relations

    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Stock Quote
    • Stock Lookup
    • Contact Us
  • CONTACT US
  • Request Information
  • Email Alerts
  • Download Library
  • RSS News Feeds
Shareholder Tools
Downloads
Print

Downloads

Jan 04, 2007
Enzon Pharmaceuticals Secures Supply of Oncaspar 11.8 KB
Dec 31, 2006
2006 Annual Report 2.2 MB
Nov 14, 2006
Enzon Pharmaceuticals Announces Effectiveness of Form S-3 Registration Statement 8 KB
Nov 09, 2006
Enzon Pharmaceuticals Announces New Data On PEG-SN38 At EORTC-NCI-AACR 15.2 KB
Nov 09, 2006
PEG-SN38 (EZN-2208) in Breast, Colorectal and Pancreatic Cancers (Abstract #145) 185.1 KB
Nov 09, 2006
Oncaspar in Solid Tumors and Lymphomas (Abstract #160) 240.2 KB
Nov 02, 2006
Enzon Pharmaceuticals Announces Second Investigational New Drug Application Approved for Novel rhMBL 12 KB
Nov 02, 2006
Enzon Reports Third Quarter 2006 Results 27.8 KB
Oct 25, 2006
Enzon to Release Earnings on Thursday November 2, 2006 8.1 KB
Sep 08, 2006
Enzon to Present at Bear Stearns 19th Annual Healthcare Conference 8.3 KB

Pagination

  • First page « first
  • Previous page ‹ previous
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Current page 17
  • Page 18
  • Page 19
  • Next page next ›
  • Last page last »

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.